BioAge Labs BIOA
NASDAQ BIOA
$5.87 +0.09 (+1.56%)
At close: Nov 11, 2026 · 4:00 PM EST

BioAge Labs (BIOA) Return on Sales [ROS] (2025 - 2026)

Updated

BioAge Labs (BIOA) posted Return on Sales [ROS] of -1196.78% for Q2 2026, down 169.79 percentage points from -1026.99% a year earlier and down 281.37 percentage points from the prior quarter.

Analysis

BioAge Labs (BIOA) Return on Sales [ROS] (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at BioAge Labs was -1026.28%, up 1337.92 percentage points year-over-year; for FY2025, it came in at -1031.46%.

  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -915.40% (Q1 2026), -923.42% (Q4 2025) and -1126.58% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 BioAge Labs 265.60 Mn -1.75 Bn -21.95 Mn -12,554.03%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -12,554.03%
Jun 30, 2026 -1,196.78%
Mar 31, 2026 -915.40%
Dec 31, 2025 -923.42%
Sep 30, 2025 -1,126.58%
Jun 30, 2025 -1,026.99%
Mar 31, 2025 -1,133.43%
API Access

BioAge Labs Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BIOA&period=max&api_key=YOUR_API_KEY